INTRODUCTION {#sec1-1}
============

Diabetes mellitus (DM) is perhaps the major health problem in developing countries resulting in major morbidity for an individual in active period of his life. Although extensive research works have been undertaken throughout the globe to understand the details of the disease, yet many aspects of the disease are yet to be explored. With improvement of public health, mortality from infectious diseases has fallen dramatically. Yet paradoxically, a marked increase in prevalence of risk factors for noncommunicable diseases such as type 2 DM, cardiovascular diseases -- hypertension, stroke, and cancer has occurred and they have become major contributors to morbidity and mortality.\[[@ref1]\] According to the data released by International Diabetes Federation in their 5^th^ edition of Diabetes Atlas, people living with diabetes is expected to rise from 366 million in 2011 to 552 million by 2030 which equates to three new cases every 10 s and 1 in 10 adults will be diabetic by 2030. India is also no exception with 61.2 million cases in 2011 and estimated 101.2 million people with type 2 DM by 2030 if no intervention is done immediately.

It is seen that, zinc plays a clear role in the synthesis, storage, and secretion of insulin as well as conformational integrity of insulin. The decreased Zn, which affects the ability of the islet cells of pancreas to produce and secrete insulin, might also lead to the development of insulin resistance compounding the problem, particularly in type 2 diabetes.\[[@ref2]\] Studies by Rai *et al*.,\[[@ref3]\] Tripathy *et al*.,\[[@ref4]\] and Oh and Yoon\[[@ref5]\] have reported indices of zinc depletion in diabetes by demonstrating reduced levels of zinc in serum and other body fluids, but no such studies are available yet from this part of our country.

Diabetes affects zinc homeostasis in many ways, although it is most probably hyperglycemia, rather than any primary lesion related to diabetes, which is responsible for the decreases in total body zinc. So, monitoring blood glucose is an essential part of diabetes management and if one has to achieve the goal of preventing and delaying the complications, proper stress on monitoring becomes important. However, routinely used direct measurement of blood glucose level in patients has a limited value since it gives information only about the glucose concentration at the time of sampling and is influenced dramatically by diet. Nevertheless, an accurate index of a person\'s mean blood glucose level over a period of 6-8 weeks can be provided by measurement of specific type of glycated hemoglobin called the hemoglobin A~1C~ (HbA~1C~) concentration in blood.\[[@ref6]\] Hence, HbA~1C~% is one parameter which provides index of blood glucose control in cumulative sense. It is a reliable indicator of long-term hyperglycemia\[[@ref7]\] and the introduction of glycated hemoglobin as a monitor of long-term glucose control has helped in identifying those at risk of developing complications. So, we have undertaken this study with an aim to evaluate the serum zinc concentration in type 2 DM patients of upper Assam and to find out any correlation between serum zinc concentration and HbA~1C~% in them.

MATERIALS AND METHODS {#sec1-2}
=====================

The present study was undertaken on newly diagnosed patients of type 2 DM in the Department of Biochemistry and Advanced Clinical Biochemistry Laboratory, Assam Medical College and Hospital, Dibrugarh, Assam from September 2010 to August 2011. After obtaining approval from Institutional Human Ethics Committee, 50 patients were selected on the basis of clinical history, examination, and relevant investigations. All the cases were above 30 years of age and selected irrespective of sex and socioeconomic status. Equal numbers of age- and sex-matched voluntary healthy subjects were taken as controls. Patients receiving zinc supplementation or taking drugs which modify metabolism of zinc, patients taking oral hypoglycemic drugs or on insulin therapy, pregnant woman or persons suffering from chronic diseases were excluded from the study. Patients were considered to be diabetic on the basis of American Diabetic Association 2010 criteria for diagnosis of DM.\[[@ref8]\] Under all aseptic and antiseptic condition, 5 mL of blood sample was collected from each subject from a suitable peripheral vein (preferably antecubital vein) by venepuncture using a sterile disposable syringe and divided into a sterile empty vial, Fluoride vial and an EDTA vial. Fluoride vials were used for Glucose estimation and EDTA vials were used for estimation of glycated hemoglobin. Different parameters were estimation on Merck Microlab 300 Semi automated analyzer. All the reagent kits used were manufactured by Coral Clinical Systems. Serum Zinc was estimated by colorimetric method,\[[@ref9][@ref10]\] glycated haemoglobin by ion exchange resin method,\[[@ref7][@ref11][@ref12]\] blood glucose (fasting and postprandial) by Glucose oxidase/Peroxidase method,\[[@ref13][@ref14]\] blood urea by modified Berthelot method,\[[@ref15][@ref16]\] and Sr. creatinine by alkaline picrate method.\[[@ref17][@ref18]\] Statistical analysis of the data was performed by using Microsoft Excel software. A '*P*' value of less than or equal to 0.05 was considered significant. Correlation was found out in SPSS by using regression equation.

RESULTS AND DISCUSSION {#sec1-3}
======================

In our study, out of the 50 cases, 35 were males and 15 were females. Age distribution of the study subjects is shown in [Table 1](#T1){ref-type="table"}. It was observed that the mean fasting blood glucose and postprandial blood glucose in newly diagnosed type 2 DM cases were found to be very significantly higher than that of the controls with *P* \< 0.001 as shown in [Figure 1](#F1){ref-type="fig"}. In the present study, it is observed that the mean serum zinc concentration in newly diagnosed male type 2 DM cases has been 80.83 ± 13.1 μg/dL and that in female cases, 77.56 ± 14.2 μg/dL. Here, the difference between male and female cases is very minimal and statistically not significant (*P* \> 0.05). Similar results were also obtained by Kinlaw *et al*.,\[[@ref19]\] and Zalewski P *et al*.\[[@ref20]\] Williams *et al*.,\[[@ref21]\] in their study, found no significant difference in serum zinc concentration between male and female cases.
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It is also observed in the present study that the mean serum zinc concentration of the 50 cases is 79.85 ± 13.4 μg/dL and that in controls is 109.74 ± 9.72 μg/dL \[[Figure 2](#F2){ref-type="fig"}\]. Hence, the serum zinc concentration in cases is lower than the concentration in controls and it is statistically highly significant (*P* \< 0.001).
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This is in accordance with McNair *et al*.,\[[@ref22]\] who reported a definite hypozincemia in 39.7% of the patients. Serum zinc correlated inversely with the glycemic status of the cases and *P* value is less than 0.005 in that study. Garg *et al*.,\[[@ref23]\] also reported hypozincemia in DM. Williams *et al*.,\[[@ref21]\] reported DM to be a condition most frequently associated with hypozincemia, where they observed 17% decrease in serum zinc concentration in diabetics, compared with controls (*P* \< 0.0001).

[Table 2](#T2){ref-type="table"} shows that the mean HbA~1C~% of the 50 cases is 8.32% ± 1.58% and that in controls is 4.72% ± 0.78%. Hence, the HbA~1C~% in cases is higher than the concentration in controls and it is statistically highly significant (*P* \< 0.001). This finding is almost consistent with Trivelli *et al*.,\[[@ref11]\] who observed that mean values for the proportions of fast hemoglobin components or glycohemoglobin in diabetes showed a nearly two-fold increase over values found in normal subjects. Similar findings were reported by Nathan *et al*.,\[[@ref7]\] Diabetes Control and Complications Trial Research Group in 1993,\[[@ref24]\] United Kingdom Prospective Diabetes Study (UKPDS),\[[@ref25]\] Khaw\[[@ref26]\] and Verma\[[@ref27]\] which strongly establishes the role of HbA~1C~ in type 2 DM.
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The range, mean, and standard deviation of HbA~1c~% in study subjects
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In the present study, it is observed that the mean HbA~1C~ concentration in newly diagnosed type 2 DM cases have an inverse relation with serum zinc concentration. From [Figure 3](#F3){ref-type="fig"}, it is evident that the cases having lower values of HbA~1C~ have higher values of serum zinc concentration and vice versa. The Pearson correlation coefficient '*r*' is found to be --0.804 which also establishes the strong negative correlation between these two parameters. Rai *et al*.,\[[@ref3]\] showed that serum zinc concentrations were lower in diabetics as compared to controls and found a negative correlation with the glycated proteins in blood. Tripathy *et al*.,\[[@ref4]\] found a significant negative correlations between serum Zn and HbA1C % with '*r*' value of --0.408 and diabetic subjects of the study were also found to have lower levels of Zn in serum as compared with healthy controls.
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The findings of the present study are consistent with Reefat *et al*.,\[[@ref28]\] who showed significant negative correlation between serum zinc concentration and baseline HbA1c% value in the diabetic group and found correlation coefficient '*r*' to be --0.33. Oh and Yoon\[[@ref5]\] also reported similar findings in their study of zinc supplementation in glycemic control of type 2 diabetic patients. Marchesini *et al*.,\[[@ref29]\] explained hypozincemia seen in the diabetic population due to the low gastrointestinal absorption and high urinary excretion of zinc in diabetic patients.

When we have done regression analysis by taking *y* = HbA1C% and *x* = Conc. of Sr. Zinc in the equation, *y* = a + bx, it reveals that *a* = 15.916 and *b* = (−0.095) and the equation becomes,

HbA~1C~% = 15.916--0.095 × Conc. of Sr. Zinc

So, HbA~1C~% can also be calculated from the value of serum zinc concentration.

In view of the above, it may be concluded that there is significant reduction of serum zinc in type 2 DM patients although it is still not clear which came first: The effects of DM and hyperglycemia on zinc metabolism or the effects that follow alterations in Zn homeostasis on carbohydrate metabolism. There is evidence that hyperglycemia interferes with the active transport of Zn back into the renal tubular cells leading to hyperzincuria. Moreover, Zn also increases insulin sensitivity by increasing the binding ability of insulin to its receptors.\[[@ref2]\] So, it is a combination of multiple and interacting effects.

Our data suggest that in this study population of upper Assam, the serum Zn concentration is decreased and it would be interesting, in subsequent studies, to see the effectiveness of any intervention undertaken in this population of the easternmost part of the country.
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